Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Tolerability in Healthy Volunteers”

4,367 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,367 results

Early research (Phase 1)Study completedNCT02104765
What this trial is testing

LY2951742 in Healthy Japanese and Caucasian Participants

Who this might be right for
Migraine Disorders
Eli Lilly and Company 45
Early research (Phase 1)Looking for participantsNCT06809400
What this trial is testing

LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Who this might be right for
Parkinson Disease
Eli Lilly and Company 127
Early research (Phase 1)Study completedNCT02316756
What this trial is testing

A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects

Who this might be right for
Healthy Subjects
Pfizer 18
Early research (Phase 1)Study completedNCT02340572
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080

Who this might be right for
Healthy
Pieris Pharmaceuticals GmbH 48
Early research (Phase 1)Study completedNCT01814839
What this trial is testing

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 85
Early research (Phase 1)Study completedNCT04734275
What this trial is testing

Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers

Who this might be right for
Chronic Kidney Disease
AstraZeneca 16
Early research (Phase 1)Study completedNCT01243502
What this trial is testing

Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers

Who this might be right for
Safety
Creabilis SA 16
Early research (Phase 1)Study completedNCT04079101
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy Volunteers
Biogen 31
Early research (Phase 1)Study completedNCT02063230
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Who this might be right for
Solid Tumors
AstraZeneca 32
Early research (Phase 1)Study completedNCT01538667
What this trial is testing

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases

Who this might be right for
Respiratory System
Bayer 24
Early research (Phase 1)Study completedNCT00912353
What this trial is testing

AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 56
Early research (Phase 1)Study completedNCT06836037
What this trial is testing

A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 56
Early research (Phase 1)Study completedNCT02616445
What this trial is testing

Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Actinogen Medical 40
Early research (Phase 1)Study completedNCT03919409
What this trial is testing

First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants

Who this might be right for
Healthy Volunteers
Taisho Pharmaceutical R&D Inc. 70
Early research (Phase 1)Looking for participantsNCT07287033
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy

Who this might be right for
Peanut Allergies
Mabylon AG 48
Early research (Phase 1)Study completedNCT06963411
What this trial is testing

Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers

Who this might be right for
Acute Allergic ReactionAnaphylaxis
Kokua Pharma Inc. 16
Early research (Phase 1)Study completedNCT02174835
What this trial is testing

A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers

Who this might be right for
Healthy
Avanir Pharmaceuticals 56
Early research (Phase 1)Study completedNCT06385964
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients

Who this might be right for
Healthy SubjectsAsthmatic Patients
Guangdong Hengrui Pharmaceutical Co., Ltd 62
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Looking for participantsNCT06867393
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects

Who this might be right for
Healthy Subjects
Shanghai Kechow Pharma, Inc. 52
Load More Results